Ligand · TOI
TOI · (1~{R},2~{S},5~{S},6~{S})-2-[(1~{S})-1-[3-[(4-azanylidene-2-methyl-1~{H}-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl (phosphonooxy)phosphoryl]oxyethyl]-1,3-thiazol-3-ium-2-yl]-1,4-bis(oxidanyl)-4-oxidanylidene-butyl]-6-oxidanyl-5-(3-oxid anyl-3-oxidanylidene-prop-1-en-2-yl)oxy-cyclohex-3-ene-1-carboxylic acid
TOI, (1~{R},2~{S},5~{S},6~{S})-2-[(1~{S})-1-[3-[(4-azanylidene-2-methyl-1~{H}-pyrimidin-5-yl)methyl]-4-methyl-5-[2-[oxidanyl…
- Component
- TOI
- Formula
- C26 H35 N4 O16 P2 S +1
- Class
- ligand
- Structures
- 2
- PDB entries
- 2
Binding sites
TOI in 2 structures; the first of them:
- 5ESU · Crystal Structure of M. tuberculosis MenD bound to Mg2+ and Covalent Intermediate II (a… · TOI C601 · binds PRO27, GLY28, SER29, ARG30, GLU55, THR78, THR81, ALA82 and 26 more
- 6O04 · M.TB mend intii bound with inhibitor · TOI D602 · binds PRO27, GLY28, SER29, ARG30, GLU55, THR78, THR81, ALA82 and 26 more
Residues it binds most
GLY 4, ARG 4, ALA 4, ASP 4, THR 4, ASN 4, ILE 4, LEU 4, PRO 4, SER 4 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.